Humanigen, Inc.
Humanigen, Inc. (HGENQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HGENQ · as of Jun 9, 2026
Key Statistics
Explore Humanigen, Inc. Data
hgenq stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 16.7%
Competitors & Peers
hgenq competitorsHGENQ
CTBO
DGCRF
GLSHQ
GNBT
NAVBStock Performance
Full HistoryAbout Humanigen, Inc.
Humanigen, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies that prevent and manage an overactive immune response. At the forefront of its pipeline is lenzilumab, a mo…
what is humanigen, inc. · hgenq stock overview · humanigen, inc. company profile · who is humanigen, inc. ceo · hgenq OTC · humanigen, inc. headquarters · humanigen, inc. business segments
About Stock Overview & Key Data
Humanigen, Inc. (HGENQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 31, 2013. As of the latest trading session, HGENQ stock price is $0.00, with a market capitalization of $23,816. The stock has returned -98.78% over the past 12 months and -84.62% year-to-date.
Frequently Asked Questions
As of the latest trading session, Humanigen, Inc. (HGENQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol HGENQ. The 52-week range is $1.00 – $5.00.